With the emergence of single gene sequencing technology, precise application of immunotherapy, huge biomedical data and various new biomarkers, the core of precisionmedicine lies not only in medical and scientific research, but also in the collaboration of industry and academia.Only scientific research institutes, medical institutions, pharmaceutical enterprises, biotechnology companies, IVD and testing companies, IT companies are able to empower the precision medicine industry and work together in order to ultimately benefit the majority of patients.

Since 2016, P4 China has successfully held three annual grand meetings, including 10+ academicians,20+ senior executives of international guests and scholars,50+ government officials, more than 250 top-ranking experts and scholars, and more than 2600 industry elites,at home and abroad,to explore the transformation of medical research results, speed up enterprise research and development, and jointly explore the road of China's precision medicine development!

"P4 China 2019 4th International Precision Medicine Convention " will be upgraded on the basis of rich experience successfully held in the past three years. More than 80 leading entrepreneurs, scientists and medical researchers will be invited to share multi-disciplinary research, analysis and mining of big biomedical data and application of artificial intelligence, early screening and early diagnosis of diseases, clinical individualized medication,precise drug development and real world research in five special forums,which will bring about an ideological collision between industry, university and research.